The effectiveness of a CpG motif-based adjuvant (CpG ODN 2006) for LHRH immunization

Vaccine

Volumn 25, Issue 35, 2007, Pages 6537-6543

  Conforti, Valéria A ^a   de Avila, David M ^a   Cummings, Nada S ^a   Wells, Kenny J ^a   Ülker, Hasan ^b   Reeves, Jerry J ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

CpG ODN; LHRH immunization; Mycobacterium butyricum

Indexed keywords

ACETIC ACID ETHYL ESTER; CPG OLIGONUCLEOTIDE; DICHLOROMETHANE; IMMUNOLOGICAL ADJUVANT; IMMUNOSTIMULATING AGENT; ORGANIC SOLVENT; RECOMBINANT OVALBUMIN LUTEINIZING HORMONE RELEASING HORMONE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; UREA;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; FREEZE DRYING; IMMUNOGENICITY; MYCOBACTERIUM BUTYRICUM; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETATES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIGENS; CONTRACEPTION, IMMUNOLOGIC; ESCHERICHIA COLI; FEMALE; FREEZE DRYING; GONADOTROPIN-RELEASING HORMONE; IMMUNIZATION; METHYLENE CHLORIDE; MYCOBACTERIUM; OLIGODEOXYRIBONUCLEOTIDES; ORGAN SIZE; OVALBUMIN; OVARY; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; VACCINES;

EID: 34547561125     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.056     Document Type: Article

References (22)

1. Zhang Y., Rozell T.G., de Avila D.M., Bertrand K.P., and Reeves J.J. Development of recombinant ovalbumin-luteinizing hormone releasing hormone as a potential sterilization vaccine. Vaccine 17 17 (1999) 2185-2191
2. Sosa J.M., Zhang Y., de Avila D.M., Bertrand K.P., and Reeves J.J. Technical note: recombinant LHRH fusion protein suppresses estrus in heifers. J Anim Sci 78 (2000) 1310-1312
3. Hernandez J.A., Zanella E.L., Bogden R., de Avila D.M., and Reeves J.J. Reproductive characteristics of grass-fed, luteinizing hormone-releasing hormone-immunocastrated Bos indicus bulls. J Anim Sci 83 12 (2005) 2901-2907
4. Gendimenico G.J., and Mezick J.A. Effects of topical inflammatory agents on Freund's adjuvant-induced skin lesions in rats. Inflamm Res 44 (1995) 16-20
5. Haak T., Delverdier M., Amardeilh M.F., Oswald I.P., and Toutain P.L. Pathologic study of an experimental canine arthritis induced with complete Freund's adjuvant. Clin Exp Rheumathol 14 6 (1996) 633-641
6. Zhang Y., Palmer G.H., Abbott J.R., Howard C.J., Hope J.C., and Brown W.C. CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum. Vaccine 21 (2003) 3307-3318
7. Antunes L.M., Golledge H.D., Roughan J.V., and Flecknell P.A. Comparison of electroencephalogram activity and auditory evoked responses during isoflurane and halothane anaesthesia in the rat. Vet Anaesth Analg 30 1 (2003) 15-23
8. Zar J.H. Biostatistical analysis. 5th ed. (2006), Prentice Hall, Upper Saddle River, NJ
9. Carpenter J.F., Prestrelski S.J., and Arakawa T. Separation of freeze- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. Arch Biochem Biophys 303 2 (1993) 456-464
10. Costantino H.R., Schwendeman S.P., Griebenow K., Klibanov A.M., and Langer R. The secondary structure and aggregation of lyophilized tetanus toxoid. J Pharm Sci 85 (1996) 1290-1293
11. Carpenter J.F., and Crowe J.H. An infrared spectroscopic study of the interactions of the carbohydrates with dried proteins. Biochemistry 28 (1989) 3916-3922
12. Braun A., Kwee L., Labow M.A., and Alsenz J. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-α) in normal and transgenic mice. Pharm Res 14 (1997) 1472-1478
13. Van de Weert M., Hennink W.E., and Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 17 (2000) 1159-1167
14. Jiang W., and Schwendeman S.P. Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres. J Pharm Sci 90 (2001) 1558-1569
15. Alonso M.J., Gupta R.K., Min C., Siber G.R., and Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12 (1994) 299-306
16. Cleland J.L., and Jones A.J.S. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm Res 13 (1996) 1464-1475
17. Sah H. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. PDA J Pharm Sci Technol 53 (1999) 3-10
18. Zambaux M.F., Bonneaux F., Gref R., Dellacherie E., and Vigneron C. Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release 60 (1999) 179-188
19. Takeshita F., Leifer C.A., Gursel I., Ishii K.J., Takeshita S., Gursel M., et al. Cutting edge: role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167 (2001) 3555-3558
20. Vollmer J., Weeratna R.D., Jurk M., Samulowitz U., McCluskie M.J., Payette P., et al. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113 (2004) 212-223
21. Christoffersen B., Raun K., Svendsen O., Fledelius C., and Golozoubova V. Evalution of the castrated male Sprague-Dawley rat as a model of the metabolic syndrome and type 2 diabetes. Int J Obes 30 (2006) 1288-1297
22. Stevens J.D., Sosa J.M., de Avila D.M., Oatley J.M., Bertrand K.P., Gaskins C.T., et al. Luteinizing hormone-releasing hormone fusion protein vaccines block estrous cycle activity in beef heifers. J Anim Sci 83 (2005) 152-159